Literature DB >> 15737515

Antibiotic-induced apoptosis in human activated peripheral lymphocytes.

Jun-Ichi Kadota1, Syunji Mizunoe, Kenji Kishi, Issei Tokimatsu, Hiroyuki Nagai, Masaru Nasu.   

Abstract

Long-term administration of macrolide antibiotics reduced the number of lymphocytes in bronchoalveolar lavage fluid in patients with chronic airway inflammatory disease. To evaluate the inflammatory activity of macrolides, their effect on apoptosis of activated lymphocytes isolated from human peripheral blood was compared with that of other antibiotics. Macrolides, including clarithromycin and azithromycin, at a final concentration of 100 microg/ml accelerated apoptosis of activated lymphocytes, while other antibiotics such as fosfomycin sodium, beta-lactams--ceftazidime, piperacillin sodium and biapenem, and a quinolone, ofloxacin, did not cause significant induction of apoptosis. Our results suggest that 14- or 15-membered ring macrolides are specifically involved in the augmentation of apoptosis of activated lymphocytes, and this may be of value therapeutically for chronic airway diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15737515     DOI: 10.1016/j.ijantimicag.2004.10.009

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

Review 1.  Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.

Authors:  P M Bartold; A H du Bois; S Gannon; D R Haynes; R S Hirsch
Journal:  Inflammopharmacology       Date:  2013-02-28       Impact factor: 4.473

2.  Multiparameter screening reveals a role for Na+ channels in cytokine-induced β-cell death.

Authors:  Yu Hsuan Carol Yang; Yury Y Vilin; Michel Roberge; Harley T Kurata; James D Johnson
Journal:  Mol Endocrinol       Date:  2014-01-17

3.  Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients.

Authors:  Evangelia Fouka; Eleftheria Lamprianidou; Konstantinos Arvanitidis; Eirini Filidou; George Kolios; Paraskevi Miltiades; Emmanouil Paraskakis; Antonios Antoniadis; Ioannis Kotsianidis; Demosthenes Bouros
Journal:  Lung       Date:  2014-07-14       Impact factor: 2.584

Review 4.  Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics.

Authors:  Helen C Steel; Annette J Theron; Riana Cockeran; Ronald Anderson; Charles Feldman
Journal:  Mediators Inflamm       Date:  2012-06-21       Impact factor: 4.711

5.  Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity.

Authors:  F Ratzinger; H Haslacher; W Poeppl; G Hoermann; J J Kovarik; S Jutz; P Steinberger; H Burgmann; W F Pickl; K G Schmetterer
Journal:  Sci Rep       Date:  2014-12-11       Impact factor: 4.379

Review 6.  The immunomodulatory effects of macrolide antibiotics in respiratory disease.

Authors:  Jennifer Pollock; James D Chalmers
Journal:  Pulm Pharmacol Ther       Date:  2021-11-03       Impact factor: 3.410

Review 7.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

8.  Azithromycin synergistically enhances anti-proliferative activity of vincristine in cervical and gastric cancer cells.

Authors:  Xuezhang Zhou; Yuyan Zhang; Yong Li; Xiujing Hao; Xiaoming Liu; Yujiong Wang
Journal:  Cancers (Basel)       Date:  2012-12-04       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.